Canada markets open in 2 hours 19 minutes

MedMen Enterprises Inc. (MMEN.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.01500.0000 (0.00%)
At close: 04:12PM EDT
Full screen
Previous Close0.0150
Open0.0000
Bid0.0200 x 0
Ask0.0200 x 0
Day's Range0.0150 - 0.0150
52 Week Range0.0150 - 0.0500
Volume0
Avg. Volume0
Market Cap20.748M
Beta (5Y Monthly)1.42
PE Ratio (TTM)N/A
EPS (TTM)-0.1500
Earnings DateMay 24, 2024 - May 28, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.35
  • Business Wire

    MedMen Announces Management and Board Changes

    BOCA RATON, Fla., January 24, 2024--MedMen Enterprises Inc. ("MedMen" or the "Company") (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company, today announced that Ellen Deutsch Harrison has stepped down as the Chief Executive Officer and a Board member effective January 19, 2024 and the Board has appointed Richard Ormond as Chief Restructuring Officer. Furthermore, Michael Serruya, Executive Chairman of the Board, who has served on the Board since August 2021, has stepped down from the Board e

  • Business Wire

    MedMen Exits Arizona Market, Completing Sale of Local Operations to MINT Cannabis

    BOCA RATON, Fla., January 05, 2024--MedMen Enterprises Inc. ("MedMen" or the "Company") (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, today announced that the Company has completed the previously announced sale of its non-core business operations in Arizona to an affiliate of Mint Cannabis ("MINT Cannabis"). The pending sale of the Company’s assets in Nevada to MINT Cannabis awaits regulatory approval for completion.

  • Business Wire

    MedMen Provides Annual Filing Status Report

    BOCA RATON, Fla., December 21, 2023--MedMen Enterprises Inc. ("MedMen" or the "Company") (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, is providing this bi-weekly default status report in accordance with National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"). On November 2, 2023, the Company announced that it had been granted a management cease trade order against the Company’s CEO and CFO ("MCTO") by its principal regulator, the B